STEMCELLS INC
10-K/A, EX-27, 2000-12-05
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: STEMCELLS INC, 10-K/A, EX-23.1, 2000-12-05
Next: STEMCELLS INC, 10-K/A, EX-99, 2000-12-05



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from the consolidated
statement of earnings for the year ended December 31, 1999 and the consolidated
balance sheet at December 31, 1999 and is qualified in its entirety by reference
to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                       4,760,064
<SECURITIES>                                         0
<RECEIVABLES>                                3,000,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             8,970,855
<PP&E>                                       5,779,777
<DEPRECIATION>                               (828,401)
<TOTAL-ASSETS>                              15,780,999
<CURRENT-LIABILITIES>                        3,560,550
<BONDS>                                      2,937,083
                                0
                                          0
<COMMON>                                       186,355
<OTHER-SE>                                   3,320,048
<TOTAL-LIABILITY-AND-EQUITY>                15,780,999
<SALES>                                              0
<TOTAL-REVENUES>                             5,021,707
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            20,959,136
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             335,203
<INCOME-PRETAX>                           (15,708,626)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (15,708,626)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (15,708,626)
<EPS-BASIC>                                      (.84)
<EPS-DILUTED>                                    (.84)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission